Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy

Clinical Science

Volumn 103, Issue SUPPL. 48, 2002, Pages

  Wolf, Sabine C ^a   Amend, Thorsten ^a   Risler, Teut ^a   Amann, Kerstin ^a   Brehm, Bernhard R ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Endothelin 1; Hypertrophy; Protein kinase C

Indexed keywords

3 [2 (3,4 DIMETHOXYPHENYL)ETHOXY] 2 (4,6 DIMETHOXY 2 PYRIMIDINYLOXY) 3,3 DIPHENYLPROPIONIC ACID; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; LU 302146; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOMYOPATHY; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HEART WEIGHT; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UREMIA; WESTERN BLOTTING;

EID: 0036671814     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs103s276s     Document Type: Conference Paper

References (20)

1. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy
2. Dialysis-associated ischemic heart disease: Insights from coronary angiography
3. The clinical course of left ventricular hypertrophy in dialysis patients
4. Structural causes of cardiac dysfunction in uremia
5. Endothelin-receptor antagonists in uraemic cardiomyopathy
6. Endothelin-1 and its receptor in hypertrophic cardiomyopathy
7. Endothelin in patients with chronic renal failure
8. A protein kinase C isozyme is translocated to cytoskeletal elements on activation
9. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes
10. Localization of protein kinase C isozymes in cardiac myocytes
11. Cytoplasmic signaling pathways that regulate cardiac hypertrophy
12. Prevention of human smooth muscle cell proliferation without induction of apoptosis by the topoisomerase I inhibitor topotecan
13. Chronically elevated endothelin-1 concentrations modulate the beta-adrenergic receptor system in vitro and in vivo
14. Effects of nebivolol on proliferation and apoptosis on human coronary artery smooth muscle and endothelial cells
15. Endothelin, vascular hypertrophy, and hypertension
16. B receptors in the hypertrophic effects of ET-1 in rabbit ventricular cardiomyocytes
17. Cardiac protein kinase C expression in two models of cardiac hypertrophy associated with an activated cardiac renin-angiotensin system: Effects of experimental hyperthyroidism and genetic hypertension (the mRen-2 rat)
18. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy
19. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat
20. Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo